9 reports

Crisis intervention services typically include advice and information for individuals with HIV/ AIDS or with issues related to substance abuse, pregnancy, parenting, health matters, contraception and sexually transmitted diseases.

  • Addiction Disorder
  • United States
  • Forecast

Sharing needles when injecting a substance of abuse greatly increases the risk of HIV/ AIDS, hepatitis, tuberculosis, and other blood-borne diseases such as infections.

  • Addiction Disorder
  • World
  • Actavis plc
  • Allergan plc
  • Pfizer Inc.
  • Clinical Trial profile. 205 Trial Title
  • Official Title

Drug Addiction Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Drug Addiction Global Clinical Trials Review, H2, 2017" provides an overview of Drug Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Addiction. Report includes...

  • Addiction Disorder
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World
  • FEATURED NEWS & PRESS RELEASES

That total is higher than the combined death tolls of HIV/ AIDS, gun violence and car crashes.

  • Addiction Disorder
  • Antiseptics
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Clinical Trial profile. 206 Trial Title
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

Component ##.

  • Addiction Disorder
  • Antiseptics
  • United States
  • World
  • Alkermes plc
  • Clinical Trial profile. 414 Trial Title

Component ##.

  • Addiction Disorder
  • Antiseptics
  • Neurology
  • Therapy
  • World

THE HYPO PRODUCTION OF CORTISOL AIDS IN ALLEVIATING THE SYMPTOMS RELATED TO SMOKING AND ADDICTION.

  • Addiction Disorder
  • Therapy
  • United States
  • Product Initiative
  • MediciNova, Inc.

Drug Addiction - Overview Drug Addiction - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DRUG ADDICTION, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DRUG ADDICTION, H## 2018 Pre-Registration ## ## Filing rejected/ Withdrawn ## ## Phase II ##

  • Addiction Disorder
  • Therapy
  • United States
  • Company
  • Product Initiative

Aphios Corporation is developing APH-## (nanoformulation of tetrahydrocannabinol, delta ##-THC) for the treatment of marijuana addiction, pain in cancer and AIDS patients, cachexia in cancer and HIV/ AIDS patients as well as multiple sclerosis, chemotherapy induced na

  • Addiction Disorder
  • Opioid
  • Research And Development
  • United States
  • Company Operations